Instructor, Internal Medicine, Mayo Medical School
Internal Medicine
Dr. Naseema Gangat, MD
|
|
Give Review
Dr. Naseema Gangat works in the field of Internal Medicine. She went to medical school at Aga Khan Medical College. Naseema Gangat is a published doctor as well. She has 51 publications published. The latest was: Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets. She accepts Medicare.
Publications
- Splenomegaly and Thrombosis risk in Essential Thrombocythemia: the Mayo Clinic Experience.
- Calreticulin (CALR) variant stratified driver mutational status and prognosis in essential thrombocythemia.
- A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients.
- Mutations and Thrombosis in essential thrombocythemia: prognostic interaction with age and Thrombosis history.
- Calreticulin mutations and long-term survival in essential thrombocythemia.
- Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients.
- The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.
- Gallbladder Cancer-associated thrombotic microangiopathy.
- Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary Myelodysplastic syndromes.
- Central nervous system relapse in Acute promyelocytic leukemia: a single institution experience.
- Plasma cytokines in Polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis.
- Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets.
- Secondary Hemophagocytic Syndrome Associated with Richter's Transformation in Chronic Lymphocytic Leukemia.
- Monosomal karyotype in Philadelphia chromosome-negative Acute lymphoblastic leukemia.
- One thousand patients with primary myelofibrosis: the mayo clinic experience.
- Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients.
- Survival and Disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
- Risk factors for arterial and venous Thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.
- Monosomal karyotype in primary myelofibrosis is detrimental to both overall and Leukemia-free survival.
- DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count...
- Refined cytogenetic-risk categorization for overall and Leukemia-free survival in primary myelofibrosis: a single center study of 433 patients.
- IDH mutations and trisomy 8 in myelodysplastic syndromes and Acute myeloid leukemia.
- WHO-defined ''Myelodysplastic syndrome with isolated del(5q)'' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and...
- Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation Analysis and clinicopathologic correlates.
- Chromosome 8p11.2 translocations: prevalence, FISH Analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single ins...
- MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative Myeloproliferative neoplasms.
- Age and platelet count are IPSS-independent prognostic factors in young patients with primary myelofibrosis and complement IPSS in predicting very long or very short s...
- The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive...
- Leukocytosis at diagnosis and the risk of subsequent Thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera.
- TET2 mutations and their clinical correlates in Polycythemia vera, essential thrombocythemia and myelofibrosis.
- Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies.
- Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.
- Absence of frataxin mutations in refractory Anemia with ring sideroblasts (RARS).
- Pharmacotherapy of essential thrombocythemia.
- Pruritus in polycythemia vera is associated with a lower risk of arterial Thrombosis.
- 20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or Polycythemia vera: predictors at diagnosis.
- Cytogenetic studies at diagnosis in Polycythemia vera: clinical and JAK2V617F allele burden correlates.
- Leucocytosis in polycythaemia Vera predicts both inferior survival and leukaemic transformation.
- A Wilde diagnosis.
- Bone marrow JAK2V617F allele burden and clinical correlates in Polycythemia vera.
- The interaction between leukocytosis and other risk factors for Thrombosis in essential thrombocythemia.
- Clinical correlates of JAK2V617F allele burden in essential thrombocythemia.
- Cerebral abscesses complicating tularemia meningitis.
- Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients.
- Management of extreme Thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?
- The PRIME curriculum clinical research training during residency: response to Kohlwes et al.
- Abdominal Vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications.
- Estrogen-based hormone therapy and Thrombosis risk in women with essential thrombocythemia.
- 68-year-old man with fatigue, fever, and weight loss.
- Pulmonary infiltrates during chemotherapy-induced febrile Neutropenia: incidence, patterns and outcomes.
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Breast Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
Aga Khan Medical College
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1356350623 | |
| NPPES Provider LastName | GANGAT | |
| NPPES Provider FirstName | NASEEMA | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Hematology | |
| Total Claim Count | 50.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356350623 |
| Last Name Of The Provider | GANGAT |
| First Name Of The Provider | NASEEMA |
| View All |
Similar Doctors
|
|
Dr. Prathibha Varkey, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Amy Larsen, MD |
|
|
Dr. Linda A. Ward, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry H. Shih, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert E. Hyatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa A. Lyle, MD |
|
|
Dr. Ali Zirakzadeh, MD |
|
|
Dr. Patrick B. Johnston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark F. Liebow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joleen M. Hubbard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anil Paturi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Louis E. Ward, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eapen K. Jacob, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James N. Ingle, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. John K. Mansel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amy H. Lee, MD |
|
|
Dr. Abha S. Goyal, MD |
|
|
Dr. Maya E. Kessler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacob J. Strand, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Svetomir N. Markovic, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Carrie A. Czarnecki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chris N. Gu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Humeniuk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Minetta Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Candace Lee |